Environmental and occupational exposures in interstitial lung disease.
Journal
Current opinion in pulmonary medicine
ISSN: 1531-6971
Titre abrégé: Curr Opin Pulm Med
Pays: United States
ID NLM: 9503765
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
pubmed:
16
7
2022
medline:
10
8
2022
entrez:
15
7
2022
Statut:
ppublish
Résumé
We highlight recent advances in the understanding of how environmental and occupational exposures increase the risk of developing interstitial lung disease (ILD), and how to evaluate a patient for potential exposures. A review of emerging literature suggests that environmental and occupational exposures can be directly causal, as in the case of the pneumoconioses and smoking-related ILDs, or one of many contributors to disease, as in the case of idiopathic pulmonary fibrosis (IPF). Regardless of the level of association, exposures are clearly prevalent across all ILD subtypes studied. Inhalational exposures are increasingly recognized as an important component in the development of ILDs, and novel exposure-disease associations continue to be discovered. These exposures represent potential opportunities for further understanding the pathobiology of disease and for the prevention of these often progressive and debilitating disorders. Prospective, comprehensive data collection regarding occupational and environmental exposures are needed in ILD patients to fully elucidate specific antigens and their relationships to disease incidence and outcomes. Systematically collected exposure information will also inform potential interventions to remediate exposures and thus mitigate the course of frequently progressive and fatal diseases.
Identifiants
pubmed: 35838370
doi: 10.1097/MCP.0000000000000894
pii: 00063198-202209000-00012
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
414-420Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Blanc PD, Annesi-Maesano I, Balmes JR, et al. The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society Statement. Am J Respir Crit Care Med 2019; 199:1312–1334.
Lee CT, Adegunsoye A, Chung JH, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest 2021; 160:209–218.
Lee CT, Strek ME, Adegunsoye AA, et al. Inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function, and Survival in the Canadian Registry for Pulmonary Fibrosis. Respirology 2022; doi: 10.1111/resp.14267. Epub ahead of print.
Cottin V, Streichenberger N, Gamondès JP, et al. Respiratory bronchiolitis in smokers with spontaneous pneumothorax. Eur Respir J 1998; 12:702–704.
Kumar A, Cherian SV, Vassallo R, et al. Current concepts in pathogenesis, diagnosis, and management of smoking-related interstitial lung diseases. Chest 2018; 154:394–408.
Godbert B, Wissler MP, Vignaud JM. Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology. Eur Respir Rev 2013; 22:117–123.
Grobost V, Khouatra C, Lazor R, et al. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis. Orphanet J Rare Dis 2014; 9:191.
Akgün M. Denim production and silicosis. Curr Opin Pulm Med 2016; 22:165–169.
Leso V, Fontana L, Romano R, et al. Artificial stone associated silicosis: a systematic review. Int J Environ Res Public Health 2019; 16:568.
Blackley DJ. Resurgence of progressive massive fibrosis in coal miners: Eastern Kentucky, 2016. MMWR Morb Mortal Wkly Rep [Internet]. 2016 [cited 28 February 2022]; 65.
Yang M, Wang D, Gan S, et al. Increasing incidence of asbestosis worldwide, 1990-2017: results from the Global Burden of Disease study 2017. Thorax 2020; 75:798–800.
Barnes H, Troy L, Lee CT, et al. Hypersensitivity pneumonitis: current concepts in pathogenesis, diagnosis, and treatment. Allergy 2021; 77:442–453.
Fernández Pérez ER, Swigris JJ, Forssén AV, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest 2013; 144:1644–1651.
Barnes H, Lu J, Glaspole I, et al. Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: a scoping review. Respir Med 2021; 184:106444.
Bellou V, Belbasis L, Evangelou E. Tobacco smoking and risk for pulmonary fibrosis: a prospective cohort study from the UK Biobank. Chest 2021; 160:983–993.
Abramson MJ, Murambadoro T, Alif SM, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study. Thorax 2020; 75:864–869.
Andersson M, Blanc PD, Torén K, Järvholm B. Smoking, occupational exposures, and idiopathic pulmonary fibrosis among Swedish construction workers. Am J Ind Med 2021; 64:251–257.
Johannson KA, Vittinghoff E, Lee K, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J 2014; 43:1124–1131.
Winterbottom CJ, Shah RJ, Patterson KC, et al. Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis. Chest 2018; 153:1221–1228.
Conti S, Harari S, Caminati A, et al. The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy. Eur Respir J 2018; 51:1700397.
Yoon HY, Kim SY, Kim OJ, Song JW. Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis. Eur Respir J 2021; 57:2001877.
Koo JW, Myong JP, Yoon HK, et al. Occupational exposure and idiopathic pulmonary fibrosis: a multicentre case-control study in Korea. Int J Tuberc Lung Dis 2017; 21:107–112.
Jegal Y, Park JS, Kim SY, et al. The recent clinical features, diagnosis, management, and outcomes of idiopathic pulmonary fibrosis in Korea: analysis of the KICO registry. Tuberc Respir Dis [Internet]. 13 December 2021 [cited 3 January 2022].
Nett RJ, Cummings KJ, Cannon B, et al. Dental personnel treated for idiopathic pulmonary fibrosis at a tertiary care center - Virginia, 2000–2015. MMWR Morb Mortal Wkly Rep 2018; 67:270–273.
Reynolds C, Thanaraaj V, Sisodia R, et al. IPF risk: two's company, three's a crowd? Asbestos exposure, cigarette smoke, and MUC5B promoter polymorphism rs35705950. Findings from the idiopathic pulmonary fibrosis job exposures study (IPFJES). Eur Respir J 2020; 56(Suppl 64).
Shtraichman O, Blanc PD, Ollech JE, et al. Outbreak of autoimmune disease in silicosis linked to artificial stone. Occup Med (Lond) 2015; 65:444–450.
Marie I, Gehanno JF, Bubenheim M, et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 2014; 13:151–156.
Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006; 119:503.e1–503.e9.
Ballerie A, Cavalin C, Lederlin M, et al. Association of silica exposure with chest HRCT and clinical characteristics in systemic sclerosis. Semin Arthritis Rheum 2020; 50:949–956.
Adegunsoye A, Oldham JM, Demchuk C, et al. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med 2016; 114:53–60.
Liu H, Patel D, Welch AM, et al. Association between occupational exposures and sarcoidosis. Chest 2016; 150:289–298.
Hena KM, Yip J, Jaber N, et al. Clinical course of sarcoidosis in World Trade Center-exposed firefighters. Chest 2018; 153:114–123.
Rice MB, Li W, Schwartz J, et al. Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study. Thorax 2019; 74:1063–1069.
Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease. Am J Respir Crit Care Med 2009; 180:407–414.
Sack CS, Doney BC, Podolanczuk AJ, et al. Occupational exposures and subclinical interstitial lung disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies. Am J Respir Crit Care Med 2017; 196:1031–1039.
Salisbury ML, Hewlett JC, Ding G, et al. Development and progression of radiologic abnormalities in individuals at risk for familial interstitial lung disease. Am J Respir Crit Care Med 2020; 201:1230–1239.
Mei Q, Liu Z, Zuo H, et al. Idiopathic pulmonary fibrosis: an update on pathogenesis. Front Pharmacol 2022; 12.
Selman M, Pardo A. When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases. Eur Respir J 2021; 58.
Sgalla G, Iovene B, Calvello M, et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res 2018; 19:32.
Johannson KA, Balmes JR, Collard HR. Air pollution exposure: a novel environmental risk factor for interstitial lung disease? Chest 2015; 147:1161–1167.
Johannson KA, Barnes H, Bellanger AP, et al. Exposure assessment tools for hypersensitivity pneumonitis. An official American Thoracic Society Workshop Report. Annals ATS 2020; 17:1501–1509.
Barnes H, Morisset J, Molyneaux P, et al. A systematically derived exposure assessment instrument for chronic hypersensitivity pneumonitis. Chest 2020; 157:1506–1512.
Aronson KI, O’Beirne R, Martinez FJ, Safford MM. Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States. Respir Res 2021; 22:225.
Papali A, Hines SE. Evaluation of the patient with an exposure-related disease: the occupational and environmental history. Curr Opin Pulm Med 2015; 21:155–162.
Blanc PD, Eisner MD, Balmes JR, et al. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med 2005; 48:110–117.
Hanak V, Kalra S, Aksamit TR, et al. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med 2006; 100:610–615.
Morell F, Villar A, Ojanguren I, et al. Hypersensitivity pneumonitis and (idiopathic) pulmonary fibrosis due to feather duvets and pillows. Archiv Bronconeumol 2021; 57:87–93.
Hierarchy of controls | NIOSH | CDC [Internet]. 2021 [cited 16 March 2022].
Merler E, Bressan V, Somigliana A. Gruppo Regionale Veneto Sui Mesoteliomi Maligni. [Mesothelioma in construction workers: risk estimate, lung content of asbestos fibres, claims for compensation for occupational disease in the Veneto Region mesothelioma register]. Med Lav 2009; 100:120–132.
Gannon PF, Weir DC, Robertson AS, Burge PS. Health, employment, and financial outcomes in workers with occupational asthma. Br J Ind Med 1993; 50:491–496.